Glucose intolerance, cognitive impairment and Alzheimer's disease

Current Opinion in Neurology

Volumn 11, Issue 6, 1998, Pages 673-677

  Vanhanen, Matti ^a,b   Soininen, Hilkka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ALZHEIMER DISEASE; BRAIN METABOLISM; COGNITION; COGNITIVE DEFECT; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

AGED; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0031797832     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199812000-00011     Document Type: Review

References (63)

1. Breteler M, Claus J, Van Duijn C, Launer L, Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992; 14:59-82.
2. Koivisto K, Reinikainen K, Hänninen T, Vanhanen M, Helkala E-L, Mykkänen L, et al. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 1995; 45:741-747.
3. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 1987; 36:523-534.
4. Andersson DKG, Svärdsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabet Med 1991; 8:428-434.
5. World Health Organization. Diabetes mellitus: report of a WHO study group, Tech Rep Ser No. 727. Geneva: World Health Organization; 1985.
6. Yudkin JS, Alberti KGM, McLarty D, Swai AB. Impaired glucose tolerance. Is it a risk factor for diabetes or a diagnostic ragbag? Br Med J 1990; 301:397-402.
7. Agner E, Thorsteinsson B, Eriksen M. Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care 1982; 5:600-604.
8. Mykkänen L, Laakso M, Uusitupa M, Pyörälä K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990; 13:1099-1105.
9. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1606.
10. Miles WR, Root HF. Psychologic tests applied to diabetic patients. Arch Intern Med 1922; 30:767-77.
11. Richardson JT. Cognitive function in diabetes mellitus. Neurosci Biobehav Rev 1990; 14:385-388.
12. Tun PA, Natham DM, Perlmuter LC. Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med 1990; 6:731-746.
13. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfuction? Diabetes Care 1997; 20:438-445. This is a comprehensive review of the case-control studies of cognitive function. Only studies with clearly identified NIDDM patients are included.
14. Meuter F, Thomas W, Grüneklee D, Gries FA, Lohman R. Psychometric evaluation of performance in diabetes mellitus. Horm Metab Res 1980; 9:9-17.
15. Perlmuter LC, Hakami MK, Hodgson-Harrington C, Ginsberg J, Katz J, Singer J, et al. Decreased cognitive function in aging non-insulin dependent diabetic patients. Am J Med 1984; 77:1043-1048.
16. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JD. Cortical function in elderly non-insulin-dependent diabetic patients. Arch Intern Med 1988; 148:2369-2373.
17. Reaven GM, Thompson LW, Nahum D, Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990; 13:16-21.
18. U'Ren RC, Riddle MC, Lezak MD, Bennington-Davis M. The mental efficiency of the elderly patients with type II diabetes mellitus. J Am Geriatr Soc 1990; 38:505-510.
19. Jagusch W, Cramon DYV, Renner R, Hepp KD. Cognitive function and metabolic state in elderly diabetic patients. Diab Nutr Metab 1992; 5:265-274.
20. Worrall G, Moulton N, Briffett E. Effect of type II diabetes mellitus on cognitive function. J Fam Pract 1993; 36:639-643.
21. Helkala EL, Niskanen L, Viinamäki H, Partanen J, Uusitupa M. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 1995; 18:681-685.
22. Ryu N, Chin K. Decreased brain function in patients with non-insulin-dependent diabetes mellitus [in Japanese]. No To Shinkei 1995; 47:543-548.
23. Zaslavsky LMA, Gross JL, Chaves ML, Machado R. Memory dysfunction and autonomic neuropathy in non-insulin-dependent (type 2) diabetic patients. Diab Res Clin Pract 1995; 30:101-110.
24. Ciotti G, Bonati PA, Pedrazzoni M, Butturini L, Mantovani M, Cucinotta D. Mental deterioration in elderly subjects with type 2 diabetes mellitus [in Italian]. G Clin Med 1986; 67:21-23.
25. Lowe LP, Tranel D, Wallace RB, Welty TK. Type II diabetes and cognitive function. A population-based study of native Americans. Diabetes Care 1994; 17:891-896.
26. Croxson SCM, Jagger C. Diabetes and cognitive impairment: a community-based study of elderly subjects. Age 1995; 24:421-424.
27. Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care 1997; 20:32-35.
28. Kuusisto J, Koivisto K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993; 22:771-779.
29. Stolk RP, Breteler MMB, Ott A, Pols HAP, Lamberts SWJ, Grobbee DE, Hofman A. Insulin and cognitive function in an elderly population. Diabetes Care 1997; 20:792-795. This interesting study including 5510 individuals shows an association between high 2-h postload insulin level and the MMSE - large population but cognitive assessment is restricted.
30. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38:1096-1102.
31. Stem MP, Rosenthal M, Haffner SM. A new concept of impaired glucose tolerance. Arteriosclerosis 1985; 5:311-314.
32. Vanhanen M, Koivisto K, Kuusisto J, Mykkänen L, Helkala E-L, Hänninen T, et al. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998; 21:398-402.
33. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershalz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham study. Diabetes Care 1997; 20:1388-1395. Because individuals in this study were followed on a regular basis with short intervals for 28-30 years, the effect of diabetes duration was possible to evaluate reliably.
34. Vanhanen M, Koivisto K, Karjalainen L, Helkala E-L, Laakso M, Soininen H, Riekkinen P Sr. Risk for non-insulin-dependent diabetes in the normoglycemic elderly is associated with impaired cognitive function. Neuro-Report 1997 8:1527-1530.
35. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology 1995; 45:1161-1168.
36. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 1996; 39:1392-1397.
37. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ. Risk of dementia among persons with diabetes mellitus. Am J Epidemiol 1997; 145:301-308. This population-based historical cohort study shows incidence of dementia and Alzheimer's disease by diabetes status and age.
38. Sinclair AJ, Allard I, Bayer A. Observations of diabetes care in long-term institutional settings with measures of cognitive function and dependency. Diabetes Care 1997; 20:778-784.
39. Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW. Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc 1996; 44:897-904.
40. 4 allele.
41. Gonder-Fredrik L, Hall JL, Vogt J, Cox DJ, Green J, Gold PE. Memory enhancement in elderly humans: effect of glucose ingestion. Physiol Behav 1987; 41:503-504.
42. Manning CA, Hall JL, Gold PE. Glucose effects on memory and other neuropsychological tests in elderly humans. Psychol Sci 1990; 1:307-311.
43. Gold PE, Stone WS. Neuroendocrine effects on memory in aged rodents and humans. Neurobiol Aging 1988; 9:709-717.
44. Schwartz MW, Figlewicz DP, Baskin DG. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992; 13:387-414.
45. Unger J, McNeill TH, Moxley RT, White M, Mosi A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989; 31:143-157.
46. Palovick RA, Phillips MI, Kappy MS, Raizada MK. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res 1984; 309:187-191.
47. Meneilly GS, Hill A. Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr Soc 1993; 41:710-714.
48. Razay G, Wilcock GK. Hyperinsulinaemia and Alzheimer's disease. Age Ageing 1994; 23:396-399.
49. Fisman M, Gordon B, Feleki V, Helmes E, McDonald T, Dupre J. Metabolic changes in Alzheimer's disease. J Am Geriatr Soc 1988; 36:298-300.
50. Winograd C, Jacobson D, Minkoff J. Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type. Biol Psychiatry 1991; 30:507-511.
51. Landin K, Blennow K, Wallin A, Gottfries C-G. Low blood pressure and blood glucose levels in Alzheimer's disease: evidence for a hypometabolic disorder? J Intern Med 1993; 233:357-363.
52. Bucht G, Adolfson R, Lithner F, Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer's type. Acta Med Scand 1983; 213:387-392.
53. Fujisawa Y, Sasaki K, Akiyama K. Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid in patients with dementia of the Alzheimer type. Biol Psychiatry 1991; 30:1219-1228.
54. Kilander L, Boberg M, Lithell H. Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta Neurol Scand 1993; 87:294-298.
55. Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, Fleishman S, et al. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 1993; 107:926-940.
56. Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, et al. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 1996; 17:123-130.
57. 4 allele.
58. Craft S, Asthana S, Schellenberg G, Cherrier M, Baker LD, Raskind E, et al. Insulin resistance and hyperinsulinemic memory facilitation characterize AD patients without an ApoE-e4 allele [abstract]. Neurobiol Aging 1998; 19 (Suppl 2):S246. Further support is provided for the conception that insulin metabolism may affect memory function in sporadic Alzheimer's disease. This paper is now in press in the journal Neurology.
59. Hoyer S, Nitsch R, Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect 1991; 3:1-14.
60. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 1998; 105:423-138. This paper shows neuropathological data supporting the insulin hypothesis in Alzheimer's disease.
61. Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, et al. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation end products. J Neural Transm 1998; 105:439-461. The role of advanced glycation end products in Alzheimer's disease are reviewed.
62. Heitner J, Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. Neurology 1997; 49:1306-1311.
63. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin-dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 1998; 105:415-422. This paper presents an interesting hypothesis of the relationship between Alzheimer's disease and diabetes.